Clinical trials
Phase 3 Liver Cirrhosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 4 |
| 2013 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| Sanofi | 3 |
| Biotest Pharmaceuticals Corporation | 1 |
| Boehringer Ingelheim | 1 |
| Debiovision | 1 |
| Galmed Research and Development, Ltd. | 1 |
| Madrigal Pharmaceuticals, Inc. | 1 |
| SciClone Pharmaceuticals | 1 |
| University of Michigan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 14 |
| Fibrosis | 5 |
| Ascites | 4 |
| Hypertension, Portal | 4 |
| Esophageal and Gastric Varices | 3 |
| Hepatitis C | 3 |
| Hepatitis C, Chronic | 2 |
| Liver Diseases | 2 |
| Carcinoma, Hepatocellular | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.